Evoke Pharma (EVOK) EBITDA (2012 - 2025)
Evoke Pharma (EVOK) EBITDA from Sep 30, 2012 to Sep 30, 2025. The TTM Evoke Pharma (EVOK) EBITDA is -$4.73M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Evoke Pharma (EVOK) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -20.37% |
| 3 Years TTM | -14.62% |
| 5 Years TTM | -17.33% |
| 10 Years TTM | -9.02% |
| All Time TTM | +11.95% |
Annual EBITDA change of Evoke Pharma (EVOK)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$3.66M | -24.54% |
| 2024 | -$4.85M | -33.47% |
| 2023 | -$7.29M | +50.31% |
| 2022 | -$4.85M | -39.68% |
| 2021 | -$8.04M | -38.34% |
| 2020 | -$13M | +82.89% |
| 2019 | -$7.13M | -5.81% |
| 2018 | -$7.57M | -38.10% |
| 2017 | -$12M | +13.77% |
| 2016 | -$11M | -11.30% |
| 2015 | -$12M | -7.76% |
| 2014 | -$13M | +390.30% |
| 2013 | -$2.68M | +32.67% |
| 2012 | -$2.02M | -15.83% |
| 2011 | -$2.40M | -52.38% |
| 2010 | -$5.04M | -2.33% |
| 2009 | -$5.16M | +59.75% |
| 2008 | -$3.23M | +60.70% |
| 2007 | -$2.01M | N/A |
Comparison Evoke Pharma (EVOK) five years EBITDA CAGR with competitors
Evoke Pharma (EVOK) five years EBITDA CAGR is -17.35%.